KRAS and testicular cancer: Our results confirm the key role of KRAS-targeting somatic mutations, which are well modeled by gene expression in KRAS-driven tumors: colon, lung, pancreas, stomach, and testicular cancers, as well as cervical squamous carcinoma (Prior et al., 2012) (Figure 3).